161 related articles for article (PubMed ID: 24410908)
1. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra.
Zheng LF; Song J; Fan RF; Chen CL; Ren QZ; Zhang XL; Feng XY; Zhang Y; Li LS; Zhu JX
Acta Physiol (Oxf); 2014 Jun; 211(2):434-46. PubMed ID: 24410908
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.
Zheng LF; Wang ZY; Li XF; Song J; Hong F; Lian H; Wang Q; Feng XY; Tang YY; Zhang Y; Zhu JX
Brain Res; 2011 Oct; 1420():59-67. PubMed ID: 21955729
[TBL] [Abstract][Full Text] [Related]
3. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.
Toti L; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1013-23. PubMed ID: 25277799
[TBL] [Abstract][Full Text] [Related]
4. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of β1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease.
Song J; Zheng L; Zhang X; Feng X; Fan R; Sun L; Hong F; Zhang Y; Zhu J
Transl Res; 2014 Jul; 164(1):22-31. PubMed ID: 24467967
[TBL] [Abstract][Full Text] [Related]
6. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
Levandis G; Balestra B; Siani F; Rizzo V; Ghezzi C; Ambrosi G; Cerri S; Bonizzi A; Vicini R; Vairetti M; Ferrigno A; Pastoris O; Blandini F
Neurogastroenterol Motil; 2015 Dec; 27(12):1783-95. PubMed ID: 26433214
[TBL] [Abstract][Full Text] [Related]
7. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of dopamine receptors in cholinergic motoneurons of the hypoglossal nucleus in a 6-OHDA-induced Parkinson's disease rat model.
Zhou L; Wang ZY; Lian H; Song HY; Zhang YM; Zhang XL; Fan RF; Zheng LF; Zhu JX
Biochem Biophys Res Commun; 2014 Sep; 452(3):560-6. PubMed ID: 25172664
[TBL] [Abstract][Full Text] [Related]
9. Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism.
Bove C; Anselmi L; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2019 Jul; 317(1):G1-G7. PubMed ID: 31042398
[TBL] [Abstract][Full Text] [Related]
10. Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.
Pellegrini C; Antonioli L; Colucci R; Ballabeni V; Barocelli E; Bernardini N; Blandizzi C; Fornai M
Parkinsonism Relat Disord; 2015 Dec; 21(12):1407-14. PubMed ID: 26499757
[TBL] [Abstract][Full Text] [Related]
11. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats.
Zhang X; Li Y; Liu C; Fan R; Wang P; Zheng L; Hong F; Feng X; Zhang Y; Li L; Zhu J
Transl Res; 2015 Aug; 166(2):152-62. PubMed ID: 25766133
[TBL] [Abstract][Full Text] [Related]
12. Impaired nitrergic relaxation in pyloric sphincter of the 6-OHDA Parkinson's disease rat.
Fan YY; Zhang Y; Fan RF; Wang T; Yu X; Zheng LF; Zhu JX
Am J Physiol Gastrointest Liver Physiol; 2022 Jun; 322(6):G553-G560. PubMed ID: 35380456
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
14. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
15. Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism.
Brown AR; Hu B; Antle MC; Teskey GC
Exp Neurol; 2009 Nov; 220(1):162-70. PubMed ID: 19703443
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide-S prevents 6-OHDA-induced gastric dysmotility in rats.
Sinen O; Özkan A; Ağar A; Bülbül M
Brain Res; 2021 Jul; 1762():147442. PubMed ID: 33753063
[TBL] [Abstract][Full Text] [Related]
17. Alterations in TH- and ChAT-immunoreactive neurons in the DMV and gastric dysmotility in an LPS-induced PD rat model.
Zheng LF; Zhang Y; Chen CL; Song J; Fan RF; Cai QQ; Wang ZY; Zhu JX
Auton Neurosci; 2013 Oct; 177(2):194-8. PubMed ID: 23701914
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal non-motor dysfunction in Parkinson's disease model rats with 6-hydroxydopamine.
Feng XY; Yang J; Zhang X; Zhu J
Physiol Res; 2019 Apr; 68(2):295-303. PubMed ID: 30628835
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Shin KS; Choi HS; Zhao TT; Suh KH; Kwon IH; Choi SO; Lee MK
Arch Pharm Res; 2013 Jun; 36(6):759-67. PubMed ID: 23539311
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
